157 related articles for article (PubMed ID: 35789302)
41. Incidence and predictive factors for pulmonary metastases after curative resection of colon cancer.
Watanabe K; Saito N; Sugito M; Ito M; Kobayashi A; Nishizawa Y
Ann Surg Oncol; 2013 Apr; 20(4):1374-80. PubMed ID: 23196787
[TBL] [Abstract][Full Text] [Related]
42. Preoperative serum carcinoembryonic antigen elevation in stage I colon cancer: improved risk of mortality in stage T1 than in stage T2.
Shen F; Cui J; Hong X; Yu F; Bao X
Int J Colorectal Dis; 2019 Jun; 34(6):1095-1104. PubMed ID: 31016378
[TBL] [Abstract][Full Text] [Related]
43. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
44. What is the effect of laparoscopic colectomy on pattern of colon cancer recurrence? A propensity score and competing risk analysis compared with open colectomy.
Hasegawa H; Okabayashi K; Watanabe M; Ashrafian H; Harling L; Ishii Y; Sugiyama D; Seishima R; Darzi A; Athanasiou T; Kitagawa Y
Ann Surg Oncol; 2014 Aug; 21(8):2627-35. PubMed ID: 24615179
[TBL] [Abstract][Full Text] [Related]
45. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study.
Marrelli D; De Stefano A; de Manzoni G; Morgagni P; Di Leo A; Roviello F
Ann Surg; 2005 Feb; 241(2):247-55. PubMed ID: 15650634
[TBL] [Abstract][Full Text] [Related]
46. Different variables predict the outcome of patients with synchronous versus metachronous metastases of colorectal cancer.
Colloca GA; Venturino A; Guarneri D
Clin Transl Oncol; 2020 Aug; 22(8):1399-1406. PubMed ID: 31916018
[TBL] [Abstract][Full Text] [Related]
47. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
[TBL] [Abstract][Full Text] [Related]
49. Incorporation of serum carcinoembryonic antigen levels into the prognostic grouping system of colon cancer.
Ozawa H; Kotake K; Hosaka M; Hirata A; Nakagawa Y; Fujita S; Sugihara K
Int J Colorectal Dis; 2017 Jun; 32(6):821-829. PubMed ID: 28185003
[TBL] [Abstract][Full Text] [Related]
50. Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.
Giessen-Jung C; Nagel D; Glas M; Spelsberg F; Lau-Werner U; Modest DP; Schulz C; Heinemann V; Di Gioia D; Stieber P
Tumour Biol; 2015 Sep; 36(10):7897-906. PubMed ID: 25953265
[TBL] [Abstract][Full Text] [Related]
51. Radiomics analysis using contrast-enhanced CT for preoperative prediction of occult peritoneal metastasis in advanced gastric cancer.
Liu S; He J; Liu S; Ji C; Guan W; Chen L; Guan Y; Yang X; Zhou Z
Eur Radiol; 2020 Jan; 30(1):239-246. PubMed ID: 31385045
[TBL] [Abstract][Full Text] [Related]
52. Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients.
Ito S; Nakanishi H; Kodera Y; Mochizuki Y; Tatematsu M; Yamamura Y
Br J Cancer; 2005 Oct; 93(9):986-92. PubMed ID: 16205696
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of a prognostic nomogram for patients with stage II colon mucinous adenocarcinoma.
Huang J; Zhang Y; Zhou J; Fang M; Wu X; Luo Y; Huang Q; Ouyang Y; Xiao S
Int J Colorectal Dis; 2022 Oct; 37(10):2173-2184. PubMed ID: 36149446
[TBL] [Abstract][Full Text] [Related]
54. Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer.
Mayanagi S; Kashiwabara K; Honda M; Oba K; Aoyama T; Kanda M; Maeda H; Hamada C; Sadahiro S; Sakamoto J; Saji S; Yoshikawa T
Dis Colon Rectum; 2018 Jul; 61(7):803-808. PubMed ID: 29561282
[TBL] [Abstract][Full Text] [Related]
55. External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder.
May M; Bastian PJ; Brookman-May S; Fritsche HM; Bolenz C; Gilfrich C; Otto W; Trojan L; Herrmann E; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
J Urol; 2012 Apr; 187(4):1210-4. PubMed ID: 22335861
[TBL] [Abstract][Full Text] [Related]
56. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
57. Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
Ihemelandu C; Sugarbaker PH
Ann Surg Oncol; 2017 Apr; 24(4):898-905. PubMed ID: 27878480
[TBL] [Abstract][Full Text] [Related]
58. [Peritoneal recurrence prediction for colon cancer based on immunoexpression].
Ovejero Gómez VJ; Freire Salinas J; García-Berbel Molina P; Azcarretazabal González-Ontaneda T; Bermúdez García MV; Gómez Román JJ
Rev Esp Patol; 2021; 54(3):147-155. PubMed ID: 34175025
[TBL] [Abstract][Full Text] [Related]
59. High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study.
Wiratkapun S; Kraemer M; Seow-Choen F; Ho YH; Eu KW
Dis Colon Rectum; 2001 Feb; 44(2):231-5. PubMed ID: 11227940
[TBL] [Abstract][Full Text] [Related]
60. Prognostic and Predictive Model for Stage II Colon Cancer Patients With Nonemergent Surgery: Who Should Receive Adjuvant Chemotherapy?
Zhang CD; Wang JN; Sui BQ; Zeng YJ; Chen JQ; Dai DQ
Medicine (Baltimore); 2016 Jan; 95(1):e2190. PubMed ID: 26735527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
